|
|
|
|
||
|
||
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Radcliffe, U.S. ex rel. v. Purdue Pharma LP (4th Cir.), 417; (U.S., rev den), 1304
Ranbaxy Labs. Ltd.; Roche Palo Alto LLC v. (D.N.J.), 1142 Ranbaxy Pharms. Inc.; Medicis Pharm. Corp. v. (D. Del.), 622 Ranbaxy Pharms. Inc.; Takeda Chem. Indus. Ltd. v. (S.D.N.Y.), 353 Ranes v. Adams Labs. Inc. (Iowa), 235 Ratiopharm Inc.; Pfizer Ltd. v. (Canada, Fed. Ct. App.), 1065 Research Found. of State Univ. of N.Y. v. Mylan Pharms. Inc. (D. Del.), 887 Reuben; U.S. v. (D. Mass.), 90; 280; 858 Reynolds; Merck & Co. v. (U.S.), 554 Richardson v. West-Ward Pharms. Inc. (S.D. Miss.), 1277 Rick v. Wyeth Inc. (D. Minn.), 1279 Ridgeway v. Pfizer Inc. (E.D. La.), 626 Rigel Pharms. Inc. Sec. Litig., In re (N.D. Cal.), 38 River's Edge Pharms. LLC; Ferring Pharms. Inc. v. (D. Md.), 1081 RK Co. v. See (7th Cir.), 1250 Ro v. AstraZeneca Pharms. LP (Del. Super. Ct.), 1249 Roberts v. GlaxoSmithKline LLC (E.D. Tex.), 1555 Robinson v. Baxter Healthcare Corp. (E.D. Tex.), 91 Roche Molecular Sys. Inc.; Board of Trustees of the Leland Stanford Junior Univ. v. (U.S., rev grant), 1394 Roche Palo Alto LLC v. Lupin Pharms. Inc. (D.N.J.), 947 Roche Palo Alto LLC v. Ranbaxy Labs. Ltd. (D.N.J.), 1142 Rochester Drug Coop. v. Braintree Labs. (D. Del.), 678 Rost, U.S. ex rel. v. Pfizer Inc. (D. Mass.), 1214; (1st Cir.), 1398 Rosuvastatin Calcium Patent Litig., In re (D. Del.), 883 Rowatt; Wyeth v. (Nev.), 1507 Roxane Labs. Inc. v. FDA (D.D.C.), 414 Roxane Labs. Inc. v. SmithKlineBeecham Corp. (E.D. Pa.), 153 RxUSA Wholesale Inc. v. Alcon Labs. Inc. (2d Cir.), 1141 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
